Q4140 identifies Biodfence, not AlloSkin AC. Select the product code that matches the material documented as supplied.
On this page
CMS RVU26D · Effective 2026-10-01
Q4141 Skin substitute Medicare reimbursement rates in Iowa
Q4141 reports AlloSkin AC supplied for a wound, billed by square-centimeter unit alongside the related skin-substitute application procedure. Compare Q4141 office and facility rates across CMS payment localities in Iowa.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4141 in Iowa?
Iowa has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$116.44
1 of 1 localities have a supported rate.
Payment area: Iowa
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care product
About Q4141: AlloSkin AC skin substitute
Q4141 reports AlloSkin AC supplied for a wound, billed by square-centimeter unit alongside the related skin-substitute application procedure.
Q4141 identifies AlloSkin AC, a human skin allograft used as a wound-covering product. It may be used in outpatient wound care for wounds such as diabetic foot ulcers or venous leg ulcers. Wound-care physicians, podiatrists, and surgeons may apply it as part of a treatment plan. The application procedure and the product are distinct services for reporting purposes.
Report Q4141 with the primary skin-substitute application procedure, using units that reflect the square-centimeter amount documented as supplied. The record should identify AlloSkin AC, the treated wound, the amount used, and the associated application. CMS treats Q4141 as an add-on: it is billed only with a primary procedure and paid within that procedure’s global period. It is a technical-component-only code, with interpretation represented by a separate code. CMS assigns practice-expense RVUs and no physician-work RVUs to Q4141.
CMS billing rules for Q4141
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4141 compared with similar codes
Office rates for Iowa, from the same CMS release.
Q4142 identifies XCM biologic tissue matrix. Q4141 is specific to AlloSkin AC; the product name and quantity record should support the selected code.
15271 reports the application procedure for specified body sites and treatment area. Q4141 reports the AlloSkin AC product used with that procedure.
Compare Q4141 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Iowa →
Office / nonfacility
$116.44
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4141 in Iowa.
PPRRVU2026_Oct_nonQPP.csv
18,235
- Code
- Q4141
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
53
- Locality
- Iowa
- Physician work
- 1.000
- Practice expense
- 0.915
- Malpractice
- 0.397
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 0.915 | 3.4862 |
| Malpractice | 0.00 | × 0.397 | 0.0000 |
| Total RVUs | 3.4862 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Iowa$116.44
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 0.915 |
| Malpractice | 0 | 0.397 |
(0 × 1 + 3.81 × 0.915 + 0 × 0.397) × $33.4009 = $116.44
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4141 billing questions
What should be reported with Q4141?
Report Q4141 with the primary skin-substitute application procedure performed for the wound. Q4141 identifies the AlloSkin AC product, not the application service.
How are units determined?
Use units based on the square-centimeter amount of AlloSkin AC supplied, supported by the product and wound documentation.
What documentation supports Q4141?
Document the product as AlloSkin AC, the wound treated, the quantity supplied, and the related application procedure.
Does Q4141 have its own global period?
CMS classifies it as an add-on paid within the primary procedure’s global period. Bill it only with a primary procedure.
Does Q4141 include interpretation?
No. CMS identifies Q4141 as a technical-component-only code; a separate code covers interpretation.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
